Applied Clinical Trials-03-01-2022

The answers to meeting biosimulation's growing demand for talent may lie in Africa.

How CROs have adapted to recent challenges—and how they’ll continue to evolve in the future.

Brief history lesson sets stage for current state of CROs.

Industry must take advantage of "lessons learned."

Tony Clapsis, SVP, Clinical Trials Services, CVS, discusses recent advancements in the clinical trials space by CVS.

Organization says either reform European drug development rules—or lose out on global competition.

Applied Clinical Trials introduces its first ever list of CROs.

Click the title above for a link to open the Applied Clinical Trials March 2022 issue in an interactive PDF format.

Pressurized political, COVID climates greet his return to top spot.

Characterizing the long-term adoption experience of clinical technologies and capabilities—and what senior leaders can do to drive adoption within their walls.

Examining best practices in using the functional service provider model for clinical operations, pharmacovigilance, regulatory, and other areas.